Please assess the completion status of the following clinical trial:

Trial Title: OPTIMIZE IDE for the Treatment of ACS

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Subject is an eligible candidate for percutaneous coronary intervention (PCI);~* Subject has symptomatic coronary artery disease with objective evidence of ischemia or silent ischemia;~* Subject is an acceptable candidate for coronary artery bypass grafting (CABG);~* Subject has up to 3 de novo target lesions in up to 2 native coronary artery vessels, with no more than 2 lesions in a single vessel, each meeting the angiographic criteria and none of the exclusion criteria.~* Target lesion(s) must be located in a native coronary artery with a visually estimated reference vessel diameter (RVD) ≥ 2.25 mm and ≤ 4.00 mm;~Exclusion Criteria:~* The subject has cardiogenic shock, hemodynamic instability requiring inotropic or mechanical circulatory support, intractable ventricular arrhythmias, or ongoing intractable angina;~* The subject's target lesion(s) is located in the left main artery;~* The subject's target lesion(s) is located within 3 mm of the origin of the left anterior descending (LAD) coronary artery or left circumflex (LCX) coronary artery by visual estimate;~* The subject's target lesion(s) is located within a saphenous vein graft or arterial graft;~* The subject's target lesion(s) will be accessed via a saphenous vein graft or arterial graft;

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Svelte (Type: EXPERIMENTAL): None
- Control (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).